Collaborative Working with the NHS

Collaborating with the NHS to improve patient care

Teva works with NHS organisations at national, regional and local level, focussing on improving patient outcomes by implementing developments in healthcare delivery.

We’re focussed on helping patients get better access to the medicines they need, working on improving treatment options, and supporting the NHS’s drive to reduce costs. We are also looking at healthcare options that are fit for the future, like new technologies, innovative devices, and a fresh approach to services.

Collaborative Working with the NHS

We pride ourselves on taking our relationship with the NHS beyond the transactional into a more consultative and problem-solving partnership to help deliver better care in areas of mutual interest.

Active Collaborative Working projects 

These Projects allow the pharmaceutical industry to work with healthcare organisations and other organisations with the aim to enhance patient care or is for the benefit of patients. Alternatively, collaborative working projects can be conducted to benefit the NHS and, as a minimum, maintain patient care.

Executive Summary of the Collaborative Working Agreement between Teva UK Limited and University Hospitals Sussex NHS Foundation Trust: Headache Service Nursing Support Project

Toggle Expand/ Collapse

The Project is being conducted to facilitate the further improvement of the headache service, and the patient experience of the service, delivered at this Trust via the provision of short term nursing support.

Project Period: Parties have committed resources to this project that will run for a period of 6 months, which can be extended if required and if agreed by all parties.   

The Project will aim to:

  • Improve the information and education that patients receive upon diagnosis of their headache condition or when they have initiated a new therapy via attendance at educational sessions and the development and dissemination of patient educational packs
  • Develop an on boarding process for new patients referred to the service that highlights the support and services available
  • Improve the efficiency of the headache service and mitigate capacity, waiting list and failure to meet patient review targets
  • Implement and embed appropriate local, national and NICE guidelines for the treatment of headaches
  • Improve the use of NHS resources
  • Audit and collect data on the impact of this Project to allow outcome reporting and identification of any requirements for future service enhancement

Expected patient benefits for this Project include:

  • Improved patient experience of the service, potentially through education, on boarding to the service and reduced waiting lists

Expected NHS benefits for this Project include:

  • Improved service efficiency
  • Reduced use of NHS resources
  • Enhanced services configured around patient needs

Expected Teva benefits for this Project include:

  • Demonstration of Collaborative Working capabilities for future projects
  • Improving and enhancing relationships with the NHS
  • Increased awareness of Teva UK Limited within the Headache therapy area
  • Potentially increased appropriate use of medicines, including medicines manufactured and marketed by Teva

For further information please contact us

Email Tel

Executive Summary of the Collaborative Working Agreement between Teva UK Limited and Royal Free Hospital NHS Foundation Trust: Headache Service Nursing Support Project

Toggle Expand/ Collapse

The Project is being undertaken to improve the management of caseloads and facilitate the ongoing development of the headache service at The Royal Free Hospital

Project Period: Parties have committed resources to this project that will run for a period of 6 months, which can be extended if required and if agreed by all parties.  

The Project will aim to:

  • Facilitate the review of headache patients as per applicable guidelines
  • Improve the efficiency of the headache service and mitigate capacity and waiting list issues
  • Implement and embed appropriate local, national and NICE guidelines for the treatment of headaches
  • Improve the use of NHS resources
  • Facilitate the development of a headache management pathway

Expected patient benefits for this Project include:

  • Improved patient experience of the service

Expected NHS benefits for this Project include:

  • Improved service efficiency
  • Reduced use of NHS resources
  • Establish headache management pathway and enhance existing services

Expected Teva benefits for this Project include:

  • Demonstration of Collaborative Working capabilities for future projects
  • Improving and enhancing relationships with the NHS
  • Increased awareness of Teva UK Limited within the Headache therapy area
  • Potentially increased appropriate use of medicines, including medicines manufactured and marketed by Teva 

For further information please contact us

Email Tel

Executive Summary of the Collaborative Working Agreement between Teva UK Limited and Gloucestershire Hospitals NHS Foundation Trust: Headache Service Nursing Support Project

Toggle Expand/ Collapse

This Headache Service Nursing Support Project (HSNS) has been developed with the Trust to work collaboratively to help further develop and improvement of the current headache service in place via the provision of short term nursing support.

Project Period: Parties have committed resources to this project that will run for a period of 6 months, which can be extended if required and if agreed by all parties.  

The Project will aim to:

  • Improve the efficiency of the headache service and mitigate capacity, waiting list and failure to meet patient review targets
  • Facilitate the review of headache patients as per applicable guidelines
  • Implement and embed appropriate local, national and NICE guidelines for the treatment of headaches
  • Improve the use of NHS resources
  • Enhance patient experience of the service

Expected patient benefits for this Project include:

  • At minimum, improved patient experience of the headache service across multiple touchpoints

Expected NHS benefits for this Project include:

  • Improved service efficiency
  • Reduced use of NHS resources
  • Improve patient treatment review targets
  • Implantation of appropriate headache guidelines

Expected Teva benefits for this Project include:

  • Demonstration of Collaborative Working capabilities for future projects
  • Improving and enhancing relationships with the NHS
  • Increased awareness of Teva UK Limited within the Headache therapy area
  • Potentially increased appropriate use of medicines, including medicines manufactured and marketed by Teva 

For further information please contact us

Email Tel

Executive Summary of the Collaborative Working Agreement between Teva UK Limited and St George’s University Hospitals NHS Foundation Trust: Headache Service Nursing Support Project

Toggle Expand/ Collapse

The Project is co-developed with the Trust to improve in efficiencies and delivery of their headache service via the provision of short term nursing support.

Project Period: Parties have committed resources to this project that will run for a period of 6 months, which can be extended if required and if agreed by all parties.  

The Project will aim to:

  • Improve the efficiency of the headache service and mitigate capacity, waiting list and failure to meet patient review targets
  • Enhance patient experience of the service
  • Enhance and optimise the headache service database
  • Conduct an audit of the current service with the view to identify areas that have improved, following provision of this project, and further areas that need to be focussed on in the future for further service enhancement

Expected patient benefits for this Project include:

  • Improved patient experience of the service, potentially through reduced waiting lists and incoming queries handling through the Headache Inbox

Expected NHS benefits for this Project include:

  • Improved service efficiency
  • Reduced use of NHS resources
  • Enhanced services configured around patient needs
  • Identification of further service enhancement needs

Expected Teva benefits for this Project include:

  • Demonstration of Collaborative Working capabilities for future projects
  • Improving and enhancing relationships with the NHS
  • Increased awareness of Teva UK Limited within the Headache therapy area
  • Potentially increased appropriate use of medicines, including medicines manufactured and marketed by Teva 

For further information please contact us

Email Tel

Joint Working

Joint Working projects are a specific type of partnership between the NHS and the pharmaceutical industry, which aim to improve the efficiency and delivery of patient care at a local level.

To ensure that the Joint Working projects we undertake are delivered to the highest standard, we follow the Department of Health’s Best Practice Guidance and the Association of the British Pharmaceutical Industry (ABPI) Code of Practice.

We have undertaken a number of Joint Working initiatives with the NHS, in respiratory and migraine:

Active Joint Working projects 

Executive Summary of the Joint Working Agreement between Teva UK Limited and The Walton Centre: Chronic Primary Headache Service Review Project

Toggle Expand/ Collapse

The Project is being undertaken to improve the clinical management, patient satisfaction and outcomes in adults patients diagnosed with chronic primary headache disorders in the Pan Mersey area.

This will be achieved by the implementation and embedding of appropriate local, national and NICE treatment guidelines through the deployment of a clinical therapeutic review. 

Project Period: Both Parties have committed resources to this project that will run for a period of 12 months. As of June 2022, this project has been extended for a further 06 months.

The Project is designed to: 

  • Improve patient satisfaction of the healthcare service and deliver better care by offering appropriate treatment within a suitable timeframe 
  • Improve patient outcomes 
  • Improve efficiency of the Chronic Headache service and mitigate capacity, waiting list and failure to meet patient review targets 
  • Reduce hospital admissions in relation to chronic headache 
  • Implement and embed appropriate local, national and NICE guidelines for the treatment of chronic primary headaches 
  • Improve the use of NHS resources 
  • Audit and collect data on the impact of this Project to allow outcome reporting and identification of any requirements for future service enhancement 

Expected patient benefits for this Project include: 

  • Full Chronic Primary Headache review with optimisation of treatment 
  • Improved patient experience of the service, potentially through reduced waiting lists 
  • Increased identification of chronic primary headache patients that require specialist input and treatments 
  • Increased quality of life through improved management 

Expected NHS benefits for this Project include: 

  • Improved service efficiency 
  • Enhanced services that are configured around patient needs 
  • Reduced use of NHS resources 
  • Reduction in unplanned hospital admissions 
  • Optimisation of the treatment for patients with chronic primary headache 

Expected Teva benefits for this Project include: 

  • Increased awareness of Teva UK Limited within the chronic headache therapy area 
  • Demonstrating Joint Working capabilities for future projects and improving relationships with the NHS 
  • Potentially increased appropriate use of medicines, including medicines manufactured and marketed by Teva 

For further information please contact us

Email Tel

 

Original Teva Ref: CNS-GB-NP-00016
Date of preparation: December 2020

Completed Joint Working projects 

For information on our completed Joint Working projects, please contact us:

Email Tel

 

Date of preparation: May 2022
Reference: COB-GB-NP-00071